OptimizeRx Corporation (OPRX)

OptimizeRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.13	13.85	18.21	84.68	10.52	18.85
Short-Term Investments	-	-	55.93	-	-	-
Cash & Short-Term Investments	16.13	13.85	74.14	84.68	10.52	18.85
Cash Growth	-74.62%	-81.32%	-12.45%	705.21%	-44.22%	111.49%
Accounts Receivable	26.33	36.25	22.16	24.8	17.89	7.42
Other Receivables	0.06	1.04	-	-	-	-
Receivables	26.39	37.29	22.16	24.8	17.89	7.42
Prepaid Expenses	4.39	1.29	0.85	0.93	4.46	0.87
Other Current Assets	-	1.9	1.43	4.7	-	-
Total Current Assets	46.91	54.33	98.58	115.11	32.86	27.14
Property, Plant & Equipment	0.58	0.72	0.37	0.47	0.59	0.74
Goodwill	70.87	78.36	22.67	14.74	14.74	14.74
Other Intangible Assets	46.48	49.4	13.02	10.65	12.12	13.94
Other Long-Term Assets	0.36	0.57	0.01	0.01	0.01	0.08
Total Assets	165.2	183.37	134.65	140.99	60.33	56.64
Accounts Payable	2.75	2.23	1.55	0.61	0.62	0.49
Accrued Expenses	5.56	7.75	2.6	2.9	2.42	1
Current Portion of Long-Term Debt	2	2	-	-	-	-
Current Portion of Leases	0.2	0.22	0.09	0.09	0.12	0.12
Current Unearned Revenue	0.79	0.17	0.16	1.39	0.29	0.58
Other Current Liabilities	3.21	5.51	3.99	4.38	6.58	3.92
Total Current Liabilities	14.5	17.88	8.4	9.37	10.03	6.11
Long-Term Debt	33.28	34.23	-	-	-	-
Long-Term Leases	0.24	0.37	0.14	0.24	0.33	0.45
Long-Term Deferred Tax Liabilities	2.71	4.34	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	5.22
Total Liabilities	50.73	56.82	8.54	9.61	10.35	11.78
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01
Additional Paid-In Capital	198.74	190.79	172.79	166.62	85.59	78.27
Retained Earnings	-84.29	-64.26	-46.69	-35.25	-35.63	-33.42
Treasury Stock	-0	-0	-0	-	-	-
Shareholders' Equity	114.47	126.55	126.11	131.38	49.97	44.86
Total Liabilities & Equity	165.2	183.37	134.65	140.99	60.33	56.64
Total Debt	35.72	36.82	0.23	0.33	0.45	0.56
Net Cash (Debt)	-19.59	-22.97	73.91	84.35	10.07	18.29
Net Cash Growth	-	-	-12.39%	737.84%	-44.95%	105.17%
Net Cash Per Share	-1.08	-1.34	4.16	4.77	0.68	1.37
Filing Date Shares Outstanding	18.42	18.18	17.1	17.88	16.81	14.61
Total Common Shares Outstanding	18.33	18.16	17.07	17.86	15.22	14.6
Working Capital	32.4	36.45	90.18	105.74	22.83	21.03
Book Value Per Share	6.25	6.97	7.39	7.36	3.28	3.07
Tangible Book Value	-2.88	-1.2	90.41	105.99	23.11	16.18
Tangible Book Value Per Share	-0.16	-0.07	5.30	5.93	1.52	1.11
Machinery	-	0.3	0.27	0.47	0.37	0.32

Source: S&P Capital IQ. Standard template. Financial Sources.